Amyloid-β peptide-induced extracellular S100A9 depletion is associated with decrease of antimicrobial peptide activity in human THP-1 monocytes

Journal of Neuroinflammation

Volumn 10, Issue , 2013, Pages

  Lee, Eun Ok ^a   Yang, Ji Hye ^a   Chang, Keun A ^c   Suh, Yoo Hun ^b   Chong, Young Hae ^a  

^a Ewha Womans University School of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c Gachon University   (South Korea)

Author keywords

Alzheimer's disease; Antimicrobial activity; A 1 42; cytotoxicity; Innate immune response; S100A9

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CALCIUM ION; CALGRANULIN B; MONOMER; OLIGOMER; POLYPEPTIDE ANTIBIOTIC AGENT; SMALL INTERFERING RNA;

ANTIMICROBIAL ACTIVITY; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL ASSAY; CELL CULTURE; COLONY FORMING UNIT; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; ESCHERICHIA COLI; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOMODULATION; INNATE IMMUNITY; MONOCYTE; PROTEIN DEPLETION; PROTEIN SECRETION; RNA INTERFERENCE; SUPERNATANT; WESTERN BLOTTING;

EID: 84878247544     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-10-68     Document Type: Article

References (48)

1. Hampel H, Bürger K, Teipel SJ, Bokde AL, Zetterberg H, Blennow K. Core candidate neurochemical and imaging biomarkers of Alzheimer's disease. Alzheimers Dement 2008, 4:38-48. 10.1016/j.jalz.2007.08.006, 18631949.
2. Chételat G, Villemagne VL, Pike KE, Ellis KA, Bourgeat P, Jones G, O'Keefe GJ, Salvado O, Szoeke C, Martins RN, Ames D, Masters CL, Rowe CC, Australian Imaging Biomarkers and Lifestyle Study of ageing (AIBL) Research Group Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease. Brain 2011, 134:798-807. 10.1093/brain/awq383, 21310725, Australian Imaging Biomarkers and Lifestyle Study of ageing (AIBL) Research Group.
3. Lukiw WJ. Amyloid beta (Aβ) peptide modulators and other current treatment strategies for Alzheimer's disease (AD). Expert Opin Emerg Drugs 2012, 17:43-60.
4. Eikelenboom P, Veerhuis R, van Exel E, Hoozemans JJ, Rozemuller AJ, van Gool WA. The early involvement of the innate immunity in the pathogenesis of late-onset Alzheimer's disease: neuropathological, epidemiological and genetic evidence. Curr Alzheimer Res 2011, 8:142-150. 10.2174/156720511795256080, 21345167.
5. Cribbs DH, Berchtold NC, Perreau V, Coleman PD, Rogers J, Tenner AJ, Cotman CW. Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study. J Neuroinflammation 2012, 9:179. 10.1186/1742-2094-9-179, 3419089, 22824372.
6. Butchart J, Holmes C. Systemic and central immunity in Alzheimer's disease: therapeutic implications. CNS Neurosci Ther 2012, 18:64-76. 10.1111/j.1755-5949.2011.00245.x, 22070806.
7. Perera C, McNeil HP, Geczy CL. S100 Calgranulins in inflammatory arthritis. Immunol Cell Biol 2010, 88:41-49. 10.1038/icb.2009.88, 19935766.
8. van Lent PL, Grevers L, Blom AB, Sloetjes A, Mort JS, Vogl T, Nacken W, van den Berg WB, Roth J. Myeloid-related proteins S100A8/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis. Ann Rheum Dis 2008, 67:1750-1758. 10.1136/ard.2007.077800, 18055478.
9. Sroussi HY, Berline J, Palefsky JM. Oxidation of methionine 63 and 83 regulates the effect of S100A9 on the migration of neutrophils in vitro. J Leukoc Biol 2007, 81:818-824.
10. Sroussi HY, Lu Y, Villines D, Sun Y. The down regulation of neutrophil oxidative metabolism by S100A8 and S100A9: implication of the protease-activated receptor-2. Mol Immunol 2012, 50:42-48. 10.1016/j.molimm.2011.12.001, 3288784, 22204866.
11. Erez O, Romero R, Tarca AL, Chaiworapongsa T, Kim YM, Than NG, Vaisbuch E, Draghici S, Tromp G. Differential expression pattern of genes encoding for antimicrobial peptides in the fetal membranes of patients with spontaneous preterm labor and intact membranes and those with preterm prelabor rupture of the membranes. J Matern Fetal Neonatal Med 2009, 22:1103-1115. 10.3109/14767050902994796, 3560925, 19916708.
12. Hiroshima Y, Bando M, Kataoka M, Inagaki Y, Herzberg MC, Ross KF, Hosoi K, Nagata T, Kido J. Regulation of antimicrobial peptide expression in human gingival keratinocytes by interleukin-1α. Arch Oral Biol 2011, 56:761-767. 10.1016/j.archoralbio.2011.01.004, 3412402, 21316034.
13. Zimmer DB, Chaplin J, Baldwin A, Rast M. S100-mediated signal transduction in the nervous system and neurological diseases. Cell Mol Biol 2005, 51:201-214.
14. Postler E, Lehr A, Schluesener H, Meyermann R. Expression of the S-100 proteins MRP-8 and -14 in ischemic brain lesions. Glia 1997, 19:27-34. 10.1002/(SICI)1098-1136(199701)19:1<27::AID-GLIA3>3.0.CO;2-7, 8989565.
15. Engel S, Schluesener H, Mittelbronn M, Seid K, Adjodah D, Wehner HD, Meyermann R. Dynamics of microglial activation after human traumatic brain injury are revealed by delayed expression of macrophage-related proteins MRP8 and MRP14. Acta Neuropathol 2000, 100:313-322. 10.1007/s004019900172, 10965802.
16. Heneka MT, Wiesinger H, Dumitrescu OL, Riederer P, Feinstein DL, Klockgether T. Neuronal and glial coexpression of argininosuccinatesynthetase and inducible nitric oxide synthase in Alzheimer disease. J Neuropathol Exp Neurol 2001, 60:906-916.
17. Shepherd CE, Goyette J, Utter V, Rahimi F, Yang Z, Geczy CL, Halliday GM. Inflammatory S100A9 and S100A12 proteins in Alzheimer's disease. Neurobiol Aging 2006, 27:1554-1563. 10.1016/j.neurobiolaging.2005.09.033, 16253391.
18. Ha TY, Chang KA, Kim J, Kim HS, Kim S, Chong YH, Suh YH. S100a9 knockdown decreases the memory impairment and the neuropathology in Tg2576 mice. AD animal model. PLoS One 2010, 5:e8840. 10.1371/journal.pone.0008840, 2809116, 20098622.
19. Chang KA, Kim HJ, Suh YH. The role of S100a9 in the pathogenesis of Alzheimer's disease: the therapeutic effects of S100a9 knockdown or knockout. Neurodegener Dis 2012, 10:27-29. 10.1159/000333781, 22301734.
20. Zhang C, Liu Y, Gilthorpe J, van der Maarel JR. MRP14 (S100A9) protein interacts with Alzheimer beta-amyloid peptide and induces its fibrillization. PLoS One 2012, 7:e32953. 10.1371/journal.pone.0032953, 3310843, 22457725.
21. Lee EO, Kang JL, Chong YH. The amyloid-beta peptide suppresses transforming growth factor-beta1-induced matrix metalloproteinase-2 production via Smad7 expression in human monocytic THP-1 cells. J Biol Chem 2005, 280:7845-7853.
22. Ryckman C, Vandal K, Rouleau P, Talbot M, Tessier PA. Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J Immunol 2003, 170:3233-3242.
23. Chong YH, Sung JH, Shin SA, Chung JH, Suh YH. Effects of the beta-amyloid and carboxyl-terminal fragment of Alzheimer's amyloid precursor protein on the production of the tumor necrosis factor-alpha and matrix metalloproteinase-9 by human monocytic THP-1. J Biol Chem 2001, 276:23511-23517. 10.1074/jbc.M009466200, 11306564.
24. Lee EO, Kim SE, Park HK, Kang JL, Chong YH. Extracellular HIV-1 Tat upregulates TNF-α dependent MCP-1/CCL2 production via activation of ERK1/2 pathway in rat hippocampal slice cultures: inhibition by resveratrol, a polyphenolicphytostilbene. Exp Neurol 2011, 229:399-408. 10.1016/j.expneurol.2011.03.006, 21419119.
25. Soscia SJ, Kirby JE, Washicosky KJ, Tucker SM, Ingelsson M, Hyman B, Burton MA, Goldstein LE, Duong S, Tanzi RE, Moir RD. The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS One 2010, 5:e9505. 10.1371/journal.pone.0009505, 2831066, 20209079.
26. Chong YH, Shin YJ, Lee EO, Kayed R, Glabe CG, Tenner AJ. ERK1/2 activation mediates Abeta oligomer-induced neurotoxicity via caspase-3 activation and tau cleavage in rat organotypic hippocampal slice cultures. J Biol Chem 2006, 281:20315-20325. 10.1074/jbc.M601016200, 16714296.
27. Malm TM, Koistinaho M, Parepalo M, Vatanen T, Ooka A, Karlsson S, Koistinaho J. Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice. Neurobiol Dis 2005, 18:134-142. 10.1016/j.nbd.2004.09.009, 15649704.
28. Foell D, Wittkowski H, Vogl T, Roth J. S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J Leukoc Biol 2007, 81:28-37.
29. Voganatsi A, Panyutich A, Miyasaki KT, Murthy RK. Mechanism of extracellular release of human neutrophil calprotectin complex. J Leukoc Biol 2001, 70:130-134.
30. Kido J, Hayashi N, Kataoka M, Nagata T. Calprotectin expression in human monocytes:induction by porphyromonasgingivalis lipopolysaccharide, tumor necrosis factor-alpha, and interleukin-1beta. J Periodontol 2005, 76:437-442. 10.1902/jop.2005.76.3.437, 15857079.
31. Rammes A, Roth J, Goebeler M, Klempt M, Hartmann M, Sorg C. Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J Biol Chem 1997, 272:9496-9502. 10.1074/jbc.272.14.9496, 9083090.
32. Vogl T, Ludwig S, Goebeler M, Strey A, Thorey IS, Reichelt R, Foell D, Gerke V, Manitz MP, Nacken W, Werner S, Sorg C, Roth J. MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes. Blood 2004, 104:4260-4268. 10.1182/blood-2004-02-0446, 15331440.
33. Xu K, Geczy CL. IFN-gamma and TNF regulate macrophage expression of the chemotactic S100 protein S100A8. J Immunol 2000, 164:4916-4923.
34. Xu K, Yen T, Geczy CL. IL-10 up-regulates macrophage expression of the S100 protein S100A8. J Immunol 2001, 166:6358-6366.
35. Bréchard S, Plançon S, Tschirhart EJ. New insights into the regulation of neutrophil NADPH oxidase activity in the phagosome: a focus on the role of lipid and Ca(2+) signaling. Antioxid Redox Signal 2013, 18:661-676. 10.1089/ars.2012.4773, 3549206, 22867131.
36. Demuro A, Parker I, Stutzmann GE. Calcium signaling and amyloid toxicity in Alzheimer disease. J Biol Chem 2010, 285:12463-12468. 10.1074/jbc.R109.080895, 2857063, 20212036.
37. Demuro A, Smith M, Parker I. Single-channel Ca(2+) imaging implicates Aβ1-42 amyloid pores in Alzheimer's disease pathology. J Cell Biol 2011, 195:515-524. 10.1083/jcb.201104133, 3206345, 22024165.
38. Camandola S, Mattson MP. Aberrant subcellular neuronal calcium regulation in aging and Alzheimer's disease. Biochim Biophys Acta 2011, 1813:965-973. 10.1016/j.bbamcr.2010.10.005, 3032815, 20950656.
39. Ladiwala AR, Litt J, Kane RS, Aucoin DS, Smith SO, Ranjan S, Davis J, Van Nostrand WE, Tessier PM. Conformational differences between two amyloid β oligomers of similar size and dissimilar toxicity. J Biol Chem 2012, 287:24765-24773. 10.1074/jbc.M111.329763, 22547072.
40. Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature 2007, 449:819-826. 10.1038/nature06246, 17943118.
41. Striz I, Trebichavsky I. Calprotectin - a pleiotropic molecule in acute and chronic inflammation. Physiol Res 2004, 53:245-253.
42. Swangchan-Uthai T, Lavender CR, Cheng Z, Fouladi-Nashta AA, Wathes DC. Time course of defense mechanisms in bovine endometrium in response to lipopolysaccharide. Biol Reprod 2012, 87:135. 10.1095/biolreprod.112.102376, 23077171.
43. Kagan BL, Jang H, Capone R, TeranArce F, Ramachandran S, Lal R, Nussinov R. Antimicrobial properties of amyloid peptides. Mol Pharm 2012, 9:708-717. 10.1021/mp200419b, 3297685, 22081976.
44. Honjo K, van Reekum R, Verhoeff NP. Alzheimer's disease and infection: do infectious agents contribute to progression of Alzheimer's disease?. Alzheimers Dement 2009, 5:348-360. 10.1016/j.jalz.2008.12.001, 19560105.
45. Itzhaki RF, Wozniak MA, Appelt DM, Balin BJ. Infiltration of the brain by pathogens causes Alzheimer's disease. Neurobiol Aging 2004, 25:619-627. 10.1016/j.neurobiolaging.2003.12.021, 15172740.
46. Miklossy J. Emerging roles of pathogens in Alzheimer disease. Expert Rev Mol Med 2011, 13:e30.
47. Youngsteadt E. Virology. Alzheimer's risk factor also aids HIV. Science 2008, 320:1577.
48. Miklossy J. Alzheimer's disease - a neurospirochetosis. Analysis of the evidence following Koch's and Hill's criteria. J Neuroinflammation 2011, 8:90. 10.1186/1742-2094-8-90, 3171359, 21816039.